Request a copy

Full Text

• Haas H.L., Sergeeva O.A., Selbach O. Histamine in the nervous system. Physiological Reviews 2008, 88:1183-1241.
• Morse K.L., Behan J., Laz T.M., West R.E., Greenfeder S.A., Anthes J.C., et al. Cloning and characterization of a novel human histamine receptor. Journal of Pharmacology and Experimental Therapeutics 2001, 296:1058-1066.
• Nakamura T., Itadani H., Hidaka Y., Ohta M., Tanaka K. Molecular cloning and characterization of a new human histamine receptor, HH4R. Biochemical and Biophysical Research Communications 2000, 279:615-620.
• Nguyen T., Shapiro D.A., George S.R., Setola V., Lee D.K., Cheng R., et al. Discovery of a novel member of the histamine receptor family. Molecular Pharmacology 2001, 59:427-433.
• Oda T., Morikawa N., Saito Y., Masuho Y., Matsumoto S. Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes. Journal of Biological Chemistry 2000, 275:36781-36786.
• Connelly W.M., Shenton F.C., Lethbridge N., Leurs R., Waldvogel H.J., Faull R.L., et al. The histamine H4 receptor is functionally expressed on neurons in the mammalian CNS. British Journal of Pharmacology 2009, 157:55-63.
• Leurs R., Chazot P.L., Shenton F.C., Lim H.D., de Esch I.J. Molecular and biochemical pharmacology of the histamine H4 receptor. British Journal of Pharmacology 2009, 157:14-23.
• Arrang J.M., Garbarg M., Schwartz J.C. Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature 1983, 302:832-837.
• Feuerstein T.J. Presynaptic receptors for dopamine, histamine, and serotonin. Handbook of Experimental Pharmacology 2008, 184:289-338.
• Morisset S., Rouleau A., Ligneau X., Gbahou F., Tardivel-Lacombe J., Stark H., et al. High constitutive activity of native H3 receptors regulates histamine neurons in brain. Nature 2000, 408:860-864.
• Lin J.S., Dauvilliers Y., Arnulf I., Bastuji H., Anaclet C., Parmentier R., et al. An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin-/- mice and patients. Neurobiology of Disease 2008, 30:74-83.
• Parmentier R., Anaclet C., Guhennec C., Brousseau E., Bricout D., Giboulot T., et al. The brain H3-receptor as a novel therapeutic target for vigilance and sleep-wake disorders. Biochemical Pharmacology 2007, 73:1157-1171.
• Hancock A.A., Diehl M.S., Fey T.A., Bush E.N., Faghih R., Miller T.R., et al. Antiobesity evaluation of histamine H3 receptor (H3R) antagonist analogs of A-331440 with improved safety and efficacy. Inflammation Research 2005, 54(Suppl. 1):S27-S29.
• Ligneau X., Landais L., Perrin D., Piriou J., Uguen M., Denis E., et al. Brain histamine and schizophrenia: potential therapeutic applications of H3-receptor inverse agonists studied with BF2.649. Biochemical Pharmacology 2007, 73:1215-1224.
• Tokita S., Takahashi K., Kotani H. Recent advances in molecular pharmacology of the histamine systems: physiology and pharmacology of histamine H3 receptor: roles in feeding regulation and therapeutic potential for metabolic disorders. Journal of Pharmacological Sciences 2006, 101:12-18.
• Vohora D., Pal S.N., Pillai K.K. Histamine and selective H3-receptor ligands: a possible role in the mechanism and management of epilepsy. Pharmacology Biochemistry and Behavior 2001, 68:735-741.
• Brabant C., Alleva L., Quertemont E., Tirelli E. Involvement of the brain histaminergic system in addiction and addiction-related behaviors: a comprehensive review with emphasis on the potential therapeutic use of histaminergic compounds in drug dependence. Progress in Neurobiology 2010, 92:421-441.
• Panula P., Nuutinen S. Histamine and H3 receptor in alcohol-related behaviors. Journal of Pharmacology and Experimental Therapeutics 2011, 336:9-16.
• Lintunen M., Hyytia P., Sallmen T., Karlstedt K., Tuomisto L., Leurs R., et al. Increased brain histamine in an alcohol-preferring rat line and modulation of ethanol consumption by H(3) receptor mechanisms. FASEB Journal 2001, 15:1074-1076.
• Nuutinen S., Lintunen M., Vanhanen J., Ojala T., Rozov S., Panula P. Evidence for the role of histamine H3 receptor in alcohol consumption and alcohol reward in mice. Neuropsychopharmacology 2011, 36:2030-2040.
• Nuutinen S., Karlstedt K., Aitta-Aho T., Korpi E.R., Panula P. Histamine and H3 receptor-dependent mechanisms regulate ethanol stimulation and conditioned place preference in mice. Psychopharmacology 2010, 208:75-86.
• Nuutinen S., Vanhanen J., Pigni M.C., Panula P. Effects of histamine H3 receptor ligands on the rewarding, stimulant and motor-impairing effects of ethanol in DBA/2J mice. Neuropharmacology 2011, 60:1193-1199.
• Lintunen M., Raatesalmi K., Sallmen T., Anichtchik O., Karlstedt K., Kaslin J., et al. Low brain histamine content affects ethanol-induced motor impairment. Neurobiology of Disease 2002, 9:94-105.
• Nuutinen S., Vanhanen J., Maki T., Panula P Histamine h3 receptor: a novel therapeutic target in alcohol dependence?. Frontiers in Systems Neuroscience 2012, 6(36):1-7.
• Quoilin C., Didone V., Tirelli E., Quertemont E. Ontogeny of the stimulant and sedative effects of ethanol in male and female Swiss mice: gradual changes from weaning to adulthood. Psychopharmacology 2010, 212:501-512.
• Ponomarev I., Crabbe J.C. A novel method to assess initial sensitivity and acute functional tolerance to hypnotic effects of ethanol. Journal of Pharmacology and Experimental Therapeutics 2002, 302:257-263.
• Prell G.D., Hough L.B., Khandelwal J., Green J.P. Lack of a precursor-product relationship between histamine and its metabolites in brain after histidine loading. Journal of Neurochemistry 1996, 67:1938-1944.
• Nowak P., Dabrowska J., Bortel A., Biedka I., Szczerbak G., Slomian G., et al. Histamine H3 receptor agonist- and antagonist-evoked vacuous chewing movements in 6-OHDA-lesioned rats occurs in an absence of change in microdialysate dopamine levels. European Journal of Pharmacology 2006, 552:46-54.
• Prast H., Tran M.H., Fischer H., Kraus M., Lamberti C., Grass K., et al. Histaminergic neurons modulate acetylcholine release in the ventral striatum: role of H3 histamine receptors. Naunyn-Schmiedeberg's Archives of Pharmacology 1999, 360:558-564.
• LaBella F.S., Queen G., Glavin G., Durant G., Stein D., Brandes L.J. H3 receptor antagonist, thioperamide, inhibits adrenal steroidogenesis and histamine binding to adrenocortical microsomes and binds to cytochrome P450. British Journal of Pharmacology 1992, 107:161-164.
• Yang R., Hey J.A., Aslanian R., Rizzo C.A. Coordination of histamine H3 receptor antagonists with human adrenal cytochrome P450 enzymes. Pharmacology 2002, 66:128-135.
• Quertemont E., Tambour S., Tirelli E. The role of acetaldehyde in the neurobehavioral effects of ethanol: a comprehensive review of animal studies. Progress in Neurobiology 2005, 75(4):247-274.
• Brabant C., Alleva L., Grisar T., Quertemont E., Lakaye B., Ohtsu H., et al. Effects of the H3 receptor inverse agonist thioperamide on cocaine-induced locomotion in mice: role of the histaminergic system and potential pharmacokinetic interactions. Psychopharmacology 2009, 202:673-687.
• Zhang M., Ballard M.E., Pan L., Roberts S., Faghih R., Cowart M., et al. Lack of cataleptogenic potentiation with non-imidazole H3 receptor antagonists reveals potential drug-drug interactions between imidazole-based H3 receptor antagonists and antipsychotic drugs. Brain Research 2005, 1045:142-149.
• Leurs R., Tulp M.T., Menge W.M., Adolfs M.J., Zuiderveld O.P., Timmerman H. Evaluation of the receptor selectivity of the H3 receptor antagonists, iodophenpropit and thioperamide: an interaction with the 5-HT3 receptor revealed. British Journal of Pharmacology 1995, 116:2315-2321.
• Enoch M.A., Gorodetsky E., Hodgkinson C., Roy A., Goldman D. Functional genetic variants that increase synaptic serotonin and 5-HT3 receptor sensitivity predict alcohol and drug dependence. Molecular Psychiatry 2011, 16:1139-1146.
• Lovinger D.M. 5-HT3 receptors and the neural actions of alcohols: an increasingly exciting topic. Neurochemistry International 1999, 35:125-130.
• Maurice T., Casalino M., Lacroix M., Romieu P. Involvement of the sigma 1 receptor in the motivational effects of ethanol in mice. Pharmacology Biochemistry and Behavior 2003, 74:869-876.
• Hancock A.A., Diehl M.S., Faghih R., Bush E.N., Krueger K.M., Krishna G., et al. In vitro optimization of structure activity relationships of analogues of A-331440 combining radioligand receptor binding assays and micronucleus assays of potential antiobesity histamine H3 receptor antagonists. Basic & Clinical Pharmacology & Toxicology 2004, 95:144-152.
• Leurs R., Bakker R.A., Timmerman H., de Esch I.J. The histamine H3 receptor: from gene cloning to H3 receptor drugs. Nature Reviews Drug Discovery 2005, 4:107-120.
• Martz A., Deitrich R.A., Harris R.A. Behavioral evidence for the involvement of gamma-aminobutyric acid in the actions of ethanol. European Journal of Pharmacology 1983, 89(1-2):53-62.
• Silveri M.M., Spear L.P. The effects of NMDA and GABAA pharmacological manipulations on ethanol sensitivity in immature and mature animals. Alcoholism, Clinical and Experimental Research 2002, 26:449-456.
• Arrang J.M., Morisset S., Gbahou F. Constitutive activity of the histamine H3 receptor. Trends in Pharmacological Sciences 2007, 28:350-357.
• Gbahou F., Rouleau A., Morisset S., Parmentier R., Crochet S., Lin J.S., et al. Protean agonism at histamine H3 receptors in vitro and in vivo. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:11086-11091.
• Bakker R.A., Lozada A.F., van Marle A., Shenton F.C., Drutel G., Karlstedt K., et al. Discovery of naturally occurring splice variants of the rat histamine H3 receptor that act as dominant-negative isoforms. Molecular Pharmacology 2006, 69:1194-1206.
• Rouleau A., Heron A., Cochois V., Pillot C., Schwartz J.C., Arrang J.M. Cloning and expression of the mouse histamine H3 receptor: evidence for multiple isoforms. Journal of Neurochemistry 2004, 90:1331-1338.